Evaluation of Serological Tests To Identify Trypanosoma cruzi Infection in Humans and Determine Cross-Reactivity with Trypanosoma rangeli and Leishmania spp ZC Caballero, OE Sousa, WP Marques, A Saez-Alquezar, ES Umezawa Clinical and vaccine immunology 14 (8), 1045-1049, 2007 | 240 | 2007 |
Comparative phylogeography of Trypanosoma rangeli and Rhodnius (Hemiptera: Reduviidae) supports a long coexistence of parasite lineages and their … F Maia Da Silva, ACV Junqueira, M Campaner, AC Rodrigues, G Crisante, ... Molecular Ecology 16 (16), 3361-3373, 2007 | 118 | 2007 |
Betacoronavirus Genomes: How Genomic Information has been Used to Deal with Past Outbreaks and the COVID-19 Pandemic A Llanes, CM Restrepo, Z Caballero, S Rajeev, MA Kennedy, R Lleonart International journal of molecular sciences 21 (12), 4546, 2020 | 59 | 2020 |
Structurally uncommon secondary metabolites derived from endophytic fungi HE Ortega, D Torres-Mendoza, Z Caballero E, L Cubilla-Rios Journal of Fungi 7 (7), 570, 2021 | 54 | 2021 |
Extracellular vesicles could carry an evolutionary footprint in interkingdom communication R Correa, Z Caballero, LF De León, C Spadafora Frontiers in Cellular and Infection Microbiology 10, 76, 2020 | 28 | 2020 |
Seroprevalence of Toxoplasma gondii in domestic pets from metropolitan regions of Panama C Rengifo-Herrera, E Pile, A García, A Pérez, D Pérez, FK Nguyen, ... Parasite 24, 2017 | 27 | 2017 |
Phylogenetic and syntenic data support a single horizontal transference to a Trypanosoma ancestor of a prokaryotic proline racemase implicated in parasite … ZC Caballero, AG Costa-Martins, RC Ferreira, JM P Alves, MG Serrano, ... Parasites & vectors 8, 1-18, 2015 | 23 | 2015 |
Frequency of Toxoplasma gondii and Risk Factors Associated with the Infection in Stray Dogs and Cats of Panama L Fábrega, CM Restrepo, A Torres, D Smith, P Chan, D Pérez, ... Microorganisms 8 (6), 927, 2020 | 22 | 2020 |
Extracellular vesicles carrying lactate dehydrogenase induce suicide in increased population density of Plasmodium falciparum in vitro R Correa, L Coronado, Z Caballero, P Faral-Tello, C Robello, ... Scientific Reports 9 (1), 5042, 2019 | 22 | 2019 |
High sensitivity and reproducibility of in‐house ELISAs using different genotypes of Trypanosoma cruzi Z Caballero E, R Correa, MS Nascimento, A Villarreal, A Llanes, ... Parasite immunology 41 (7), e12627, 2019 | 11 | 2019 |
Analysis of the antiparasitic and anticancer activity of the coconut palm (Cocos nucifera L. ARECACEAE) from the natural reserve of Punta Patiño, Darién CS Nicole M. Tayler, Cristopher A. Boya, Liuris Herrera, Jamie Moy, Michelle ... Plos/one, 2019 | 10 | 2019 |
Building programs to eradicate toxoplasmosis Part I: Introduction and overview MS Felín, K Wang, A Moreira, A Grose, K Leahy, Y Zhou, FA Clouser, ... Current Pediatrics Reports 10 (3), 57-92, 2022 | 8* | 2022 |
Epidemiological Aspects of Maternal and Congenital Toxoplasmosis in Panama F Carlos, VC Delba, B Jovanna, F Lorena, N Ximena, SL X, ... Pathogens 10 (6), 764, 2021 | 8 | 2021 |
Building programs to eradicate Toxoplasmosis Parte II: Education Current Pediatrics Reports 10, pages 93–108 (2022), 2022 | 6 | 2022 |
P Alves JM, Serrano MG, Camargo EP, et al. Phylogenetic and syntenic data support a single horizontal transference to a Trypanosoma ancestor of a prokaryotic proline racemase … ZC Caballero, AG Costa-Martins, RC Ferreira Parasit Vectors 8, 222, 2015 | 5 | 2015 |
Building Programs to Eradicate Toxoplasmosis Part I: Introduction and Overview M Soberónfelín, P Goodall, P Levigne, C Charter, M de Frias, J Montoya, ... Current Pediatrics Reports, 2022 | 1 | 2022 |
Seroprevalencia de la toxoplasmosis congénita en la ciudad de Panamá y Panamá Oeste y factores de riesgos asociados a su transmisión. DL Villalobos Universidad de Panamá., 2019 | 1 | 2019 |
Building Programs to Eradicate Toxoplasmosis Part IV: Understanding and Development of Public Health Strategies and Advances “Take a Village” Z Caballero, X Norero, D Estripeaut, D Ellis, C Raggi, K Wang, C Castro, ... Current Pediatrics Reports, 2022 | | 2022 |
Building Programs to Eradicate Toxoplasmosis Part III: Epidemiology and Risk Factors XS Llorens, O Reyes12, R McLeod | | 2022 |
Building Programs to Eradicate Toxoplasmosis Part IV: Understanding and Development of Public Health Strategies and Advances “Take a Village” XS Llorens, O Reyes12, R McLeod | | 2022 |